| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |